Dubai: A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included  Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

About UMass Chan Medical School

UMass Chan Medical School, one of five campuses of the University of Massachusetts system, comprises the T.H. Chan School of Medicine; the Morningside Graduate School of Biomedical Sciences; the Tan Chingfen Graduate School of Nursing; ForHealth Consulting of UMass Chan Medical School, a public service health care consulting division; and MassBiologics, the only nonprofit, FDA-licensed manufacturer of vaccines, biologics and viral vector gene therapies in the United States. At UMass Chan, we are advancing together to improve the health and wellness of our diverse communities throughout Massachusetts and across the world by leading and innovating in education, research, health care delivery and public service. UMass Chan has built a reputation as a world-class destination for biomedical research, with more than $300 million in annual funding and more than 500 active clinical trials and as a leader in primary care education, perennially ranked in the top 10 percent of medical schools for primary care by U.S. News and World Report. In 2021, the Medical School received a $175 million donation from The Morningside Foundation and was renamed UMass Chan Medical School. Learn more at www.umassmed.edu.

About Dubai Health

Dubai’s first integrated academic health system was established to elevate the standard of care and to advance health for humanity. Dubai Health is comprised of 6 hospitals, 26 ambulatory health centers and 20 medical fitness centers, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and Al Jalila Foundation.  

  

Dubai Health serves patients through the integration of care, learning, discovery and giving. A team of 11,000+ collaborates across multidisciplinary teams to put the patient first. Together, everyone is all in, wholeheartedly, for patients and their families. 

 

The Dubai Academic Health Corporation (DAHC) was established as per the Law (13) of 2021 issued by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai. Effective 11 November 2023, Dubai Academic Health Corporation operates under the brand name Dubai Health. 

 

Dubai Health is comprised of the following: 

Healthcare facilities 

  • Al Jalila Children's Hospital 
  • Dubai Hospital 
  • Hatta Hospital 
  • Jebel Ali Hospital  
  • Latifa Hospital 
  • Rashid Hospital 
  • Ambulatory Health Centers 
  • Medical Fitness Centers 

 Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) 

  • Hamdan Bin Mohammed College of Dental Medicine 
  • College of Medicine 
  • College of Nursing and Midwifery 
  • Research and Graduate Studies 
  • Graduate Medical Education